Vanguard Global Advisers’s Lunai Bioworks LNAI Stock Holding History

Vanguard Global Advisers’s Portfolio LNAI Stock Details LNAI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-542	Closed	-$1.77K	–	3716
2026 Q1	$1.77K	Buy	+542	New	+$2.69K	﹤0.01%	3621

Other funds holding LNAI

GSC

Ground Swell Capital Folly Beach, South Carolina $92.6M AUM 41.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

Vanguard Global Advisers's LNAI Position: Q2 2026 in Review

Vanguard Global Advisers sold out of Lunai Bioworks (LNAI) in Q2 2026, closing a stake of 542 shares — an estimated $1.77K sold.

Vanguard Global Advisers first reported a position in LNAI in Q1 2026 and held it in 1 quarter. The position peaked at $1.77K in Q1 2026. 15 funds tracked by Wall St. Rank hold LNAI as of Q2 2026.

Vanguard Global Advisers reported no remaining Lunai Bioworks position as of Q2 2026 after selling out during the quarter.
Vanguard Global Advisers sold 542 Lunai Bioworks shares in Q2 2026, an estimated $1.77K.
Vanguard Global Advisers first reported a position in Lunai Bioworks in Q1 2026 and held it in 1 quarter.
Vanguard Global Advisers's Lunai Bioworks position peaked at $1.77K in Q1 2026.
15 funds tracked by Wall St. Rank held Lunai Bioworks as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.